menu search

Lifshitz law pllc announces investigations of rain oncology, inc. (nasdaq: rain), danaher corp. (nyse: dhr), bausch health companies, inc. (nyse: bhc), and at&t inc. (nyse: t)

NEW YORK, Sept. 02, 2023 (GLOBE NEWSWIRE) — Rain Oncology, Inc. (NASDAQ: RAIN) Lifshitz Law PLLC announces investigation into possible securities la...

September 2, 2023, 11:00 pm

Rosen, global investor counsel, encourages bausch health companies inc. investors with losses to secure counsel before important deadline in securities class action – bhc

NEW YORK, Sept. 02, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Ba...

September 2, 2023, 1:15 am

Globus medical completes merger with nuvasive

—Creates leading global musculoskeletal company——Robust portfolio well-positioned for long-term g...

September 1, 2023, 12:33 pm

Why vinfast auto stock crashed this week -- and could keep falling

VinFast stock has been cut in half this week. VinFast's ownership is complex, but the publicly traded shares represent only a min...

September 1, 2023, 10:20 am

Pepgen announces presentations at the 2023 myotonic dystrophy foundation annual conference, ottawa neuromuscular disease meeting, and h.c. wainwright 25th annual global investment conference

BOSTON, Sept. 01, 2023 (GLOBE NEWSWIRE) -- PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonu...

September 1, 2023, 8:00 am

Igo limited (ipgdf) q4 2023 earnings call transcript

IGO Limited (OTCPK:IPGDF) Q4 2023 Earnings Conference Call August 30, 2023 8:00 PM ET Company Participants Matt D...

August 31, 2023, 2:25 am

Nzd/usd spike above 60 usc short-lived

Softer than expected US economic data increased expectations of the Fed remaining on hold in September which underpinned equities and contributed to l...

August 30, 2023, 8:44 pm

Why ambarella's 20% decline is a strong signal for new investment

Ambarella's NASDAQ: AMBA stock shed 20% following the Q2 report and guidance, but don't read too much bearishness into the news. The company is focuse...

August 30, 2023, 12:59 pm

Fibrogen (fgen) fails to meet goals in dmd study, stock down 23%

FibroGen (FGEN) falls 22.7% as its late-stage study of pamrevlumab for the treatment of ambulatory patients with Duchenne m...

August 30, 2023, 12:46 pm

Fibrogen stock plummets as muscular dystrophy drug trial fails

FibroGen Inc (NASDAQ:FGEN) plummeted some 27% lower in Wednesday's early deals after revealing that its intended treatment for Duchenne m...

August 30, 2023, 9:39 am

Fibrogen shares fall after failure in late-stage study of duchenne muscular dystrophy treatment

Shares of FibroGen Inc. FGEN, +3.23% fell 23% premarket on Wednesday after the company said its investigational treatment for Duchenne m...

August 30, 2023, 7:55 am

Fibrogen announces topline results from lelantos-2, a phase 3 clinical study of pamrevlumab in ambulatory duchenne muscular dystrophy

– Study did not meet the primary endpoint – – Pamrevlumab was generally safe and well tolerated – SAN FRANCISCO, Aug. 29, 2023 (GLOBE NEWSWIRE...

August 29, 2023, 8:15 pm

Si-bone to present at morgan stanley 21st annual global healthcare conference on september 12, 2023

SANTA CLARA, Calif., Aug. 29, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving m...

August 29, 2023, 4:09 pm

Eur/jpy price analysis: despite rising, intra-day technicals favor bears

As the Asian session begins, the EUR/JPY registers minuscule losses after posting 0.31% of gains on Mon...

August 28, 2023, 10:59 pm

Nuscale power: mixed feelings about this stock

Nuscale Power Corporation's SMR technology offers a flexible and adaptable solution for nuclear power g...

August 28, 2023, 2:51 pm

Bud light falls further, modelo extends lead as best-selling us beer

After toppling Bud Light to become the best-selling beer brand in the U.S. on the year, Modelo Especial has extended its lead over the beleaguered Anh...

August 28, 2023, 2:45 pm

Scholar rock: the market isn't enthusiastic despite decent clinical data

Scholar Rock Holding Corp. is developing a growth factor targeted therapy called apitegromab for Spinal Musc...

August 27, 2023, 9:13 am

Anheuser-busch inbev: do signs of a recovery make the stock a buy?

The boycott on Bud Light in the United States shows signs of softening. Anheuser-Busch's total business...

August 27, 2023, 9:09 am

Rosen, a trusted and leading law firm, encourages bausch health companies inc. investors to secure counsel before important deadline in securities class action – bhc

NEW YORK, Aug. 26, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Ba...

August 26, 2023, 3:00 pm

Here's how bud light stock reacted to losing no.1 beer spot in 2023

Earlier this year, Anheuser Busch (NYSE: BUD), the company behind Bud Light, experienced a sharp declin...

August 25, 2023, 7:54 am


Search within

Pages Search Results: